Skip to main content
Clinical Trials/NCT03580434
NCT03580434
Completed
Not Applicable

National, Multicentre, Pilot Study, to Evaluate Safety and Performance of the V-STRUT© Transpedicular Vertebral System Indicated for Vertebral Compression Fracture Treatment

Hyprevention3 sites in 1 country9 target enrollmentFebruary 1, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Vertebral Compression Fracture
Sponsor
Hyprevention
Enrollment
9
Locations
3
Primary Endpoint
Difficulties of the procedure [feasibility of the procedure]
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

The purpose of this pilot study is to evaluate the safety and performance of the V-STRUT© Transpedicular Vertebral System for the treatment of vertebral compression fractures of the thoracic or lumbar spine.

Registry
clinicaltrials.gov
Start Date
February 1, 2019
End Date
August 1, 2022
Last Updated
3 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Unstable fractures or neoplasms with posterior involvement
  • Nonmobile fractures
  • Damages of the pedicles or posterior wall
  • Less than one third of the original vertebral body height remaining
  • Spinal canal stenosis (\>20%)
  • Neurologic signs or symptoms related to the compression fracture or impeding pathological fracture
  • Patient clearly improving on conservative treatment
  • Pregnancy, breastfeeding
  • Any contra-indication / allergy to implant material or cement
  • Any previous surgical treatment (material or cement) in the targeted vertebra

Outcomes

Primary Outcomes

Difficulties of the procedure [feasibility of the procedure]

Time Frame: per-operative

Record difficulties experienced by surgeons during the procedure: each individual step of the procedure will be recorded and quoted by practitioners as very easy, easy, difficult or very difficult.

Cement quantity injected [feasibility of the procedure]

Time Frame: per-operative

Record cement quantity injected in the vertebral body, in cc (cubic centimeter).

Operating time [feasibility of the procedure]

Time Frame: per-operative

Measuring the duration of the surgical procedures.

Hospitalisation stay [feasibility of the procedure]

Time Frame: per-operative and immediate post-op

Measuring the duration of the hospitalisation stay.

Type of anaesthesia [feasibility of the procedure]

Time Frame: per-operative

Record the type of anaesthesia as GA (General Anaesthesia), local anaesthesia + sedation, or other.

Secondary Outcomes

  • Rates of cement leakage [safety of the device](Per-operative, immediate post-op, at 2 months, 6 months and 12 months.)
  • Pain [performance of the device](pre- operative, immediate post-op, at 2 months, 6 months and 12 months.)
  • Functional score [safety of the device](per-operative, immediate post-op, at 2 months, 6 months and 12 months.)
  • Rates of fractures [safety of the device](Per-operative, immediate post-op, at 2 months, 6 months and 12 months.)
  • Frequencies of ADEs and SADEs [safety of the device](per- operative, immediate post-op, at 2 months, 6 months and 12 months.)
  • Haematomas and infections rates [safety of the device](per-operative, immediate post-op, at 2 months, 6 months and 12 months.)
  • Wound healing [safety of the device](per-operative, immediate post-op, at 2 months, 6 months and 12 months.)

Study Sites (3)

Loading locations...

Similar Trials